Sanara MedTech (SMTI) Total Non-Current Liabilities (2010 - 2026)
Sanara MedTech's (SMTI) quarterly Total Non-Current Liabilities came in at $48.6 million in Q1 2026, up 4.58% YoY from $46.4 million in Q1 2025, and little changed on a QoQ basis from $48.4 million in Q4 2025.
Sanara MedTech (SMTI) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Sanara MedTech (SMTI) has 16 years of Total Non-Current Liabilities data on file, last reported at $48.6 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 4.58% year-over-year to $48.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.6 million (up 4.58% YoY) and the FY2025 annual result came in at $48.4 million, up 42.78% from the prior year.
- Total Non-Current Liabilities steadied at $48.6 million in Q1 2026, from $48.4 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $48.6 million in Q1 2026 to a low of $187040.0 in Q1 2022.
- A 5-year average of $24.2 million and a median of $18.1 million in 2023 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities tumbled 54.8% — and 2023, when it jumped 4116.63%.
- Tracing SMTI's Total Non-Current Liabilities over 5 years: stood at $6.5 million in 2022, then surged by 138.36% to $15.5 million in 2023, then surged by 118.43% to $33.9 million in 2024, then soared by 42.78% to $48.4 million in 2025, then rose by 0.35% to $48.6 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $48.6 million (Q1 2026), $48.4 million (Q4 2025), and $47.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Sanara MedTech | 297.82 Mn | 297.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.56 Mn |
| Dec 31, 2025 | 48.39 Mn |
| Sep 30, 2025 | 47.59 Mn |
| Jun 30, 2025 | 48.50 Mn |
| Mar 31, 2025 | 46.43 Mn |
| Dec 31, 2024 | 33.89 Mn |
| Sep 30, 2024 | 34.75 Mn |
| Jun 30, 2024 | 20.42 Mn |
| Mar 31, 2024 | 15.15 Mn |
| Dec 31, 2023 | 15.52 Mn |
| Sep 30, 2023 | 18.15 Mn |
| Jun 30, 2023 | 7.43 Mn |
| Mar 31, 2023 | 7.89 Mn |
| Dec 31, 2022 | 6.51 Mn |
| Sep 30, 2022 | 7.62 Mn |
| Jun 30, 2022 | 4.10 Mn |
| Mar 31, 2022 | 187,040.00 |
| Dec 31, 2021 | 222,151.00 |
| Sep 30, 2021 | 347,011.00 |
| Jun 30, 2021 | 381,044.00 |